Glycogen Synthase Kinase 3, antagonists & inhibitors
- Name
- Glycogen Synthase Kinase 3, antagonists & inhibitors
- Accession Number
- DBCAT001442
- Description
Not Available
- Drugs
Drug Drug Description AR-AO-14418 Not Available LY-2090314 Ly2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer. Tideglusib Tideglusib was initially formulated for the treatment of Alzheimer and progressive supranuclear palsy. The raising interest for the use of tideglusib comes from the significant upregulation of GSK-3 in the... 6-bromoindirubin-3'-oxime Not Available - Drugs & Drug Targets
Drug Target Type AR-AO-14418 Glycogen synthase kinase-3 beta target Tideglusib Glycogen synthase kinase-3 beta target 6-bromoindirubin-3'-oxime Glycogen synthase kinase-3 beta target